ABGD Ventures is a $100M cross-border HealthTech fund that aims to catalyze the next generation of global healthcare infrastructure. Our One World One Health mission aims to bridge critical U.S. care gaps with clinically validated, cost-efficient innovations from India, scaling them into high-value markets. In parallel, we aim to channel transformative U.S. innovations back into India and other emerging economies to strengthen chronic care delivery and amplify infrastructure impact.

This model advances our bold vision of redefining affordable, high-quality healthcare globally with an objective to deliver outsized financial performance and measurable improvements in healthcare outcomes.

Our Thesis

ABGD Ventures aims to bridge U.S. healthcare gaps requiring transformative innovation with India’s proven ingenuity, scaling cost efficient solutions across borders to address critical care gaps. The strategy also channels U.S. innovations back into India and emerging markets to strengthen infrastructure and chronic care delivery, unlocking superior returns and redefining the framework for affordable and high quality healthcare globally.

Source

Identify clinically validated, impact-driven healthtech innovations from emerging markets through our proprietary network and strategic partnerships.

Focus on ventures with proven efficacy, regulatory readiness, and global scalability potential.

Nurture

Provide capital, operational support, and market enablement to strengthen clinical validation, compliance, and go-to-market capability.

Leverage deep domain expertise to prepare ventures for international expansion and sustainable growth.

Scale

Expand into developed, high-value markets such as the US, EU, UK, and GCC through global strategies and local partnerships.

Secure distribution, reimbursement access, and regulatory approvals that accelerate adoption.

Unlock

Drive enterprise growth, enhance valuation, and create measurable global health impact.

Position ventures for sustainable profitability and strategic exits at developed-market multiples.

Share Your Pitch

Our Impact Portfolio

DocsTrib
empaithy
respyr
Radio Clash
Gentle Dental

A Fund Built by Operators, Backed by Domain Experts

The future belongs to those building at the intersection of health and technology. At this frontier, ABGD partners with exceptional teams to accelerate change, close critical gaps, and create global enterprise value.

Proprietary Deal Flow

Strategic Access to Capital 
We offer exclusive access to top innovations through our deep industry relationships and an expansive, proprietary network.

Proven Cross-border Playbook

Proven Cross-border Playbook
Our repeatable scaling framework is supported by a proven crossborder playbook with quantifiable success metrics for effective international expansion.

Global GTM

Global Advantage
We possess deep regulatory knowledge across various international markets and extensive experience in strategic market entry for diverse global regions.

Operator-led Expertise

Operator-led Expertise
Our team comprises founders with extensive startup experience and hands-on operational knowledge acquired from successfully scaling ventures.

How We Create Value Beyond Valuation

(01)

Impact-driven Capital

Our capital flows only to ventures that align with our vision of creating high-value social impact. 

(02)

The Multiplier Effect

Global scaling and proven expertise in guiding start-ups into regulated, high-ARPU markets.

(03)

Ecosystem of Success

We have built a symbiotic ecosystem where portfolio companies flourish with the support of partners, advisors, and networks that open real doors.

(04)

Global Enterprise Value

Proprietary deal flow through strategic partnerships with incubators, academia, and leading medical institutions.

(05)

From Founders to Builders of Legacy

We create successful founders who, over time, become investors themselves and strengthen the cycle of venture success.

Bringing Global Value Through Thoughtful Investment

Stage-Agnostic. Opportunity-Focused. Value-Driven.

Stage

We back healthtech ventures that are ready to scale globally, providing growth capital without limits on stage, as long as they align with our thesis of venture success and social impact.

Geography

Our focus is on healthtech innovations that originate in emerging markets and have the potential to expand into developed, high-value markets.

Domain Focus

We invest in clinical and non-clinical solutions that leverage AI, big data, and novel technologies, along with health infrastructure and expansion models, to drive sustainable growth in health technology.

Approach

We partner hands-on with founders, providing operational expertise, market access, and board-level guidance to accelerate growth.

Unlock Value for Your Venture in Global Markets

If you are a founder building in healthtech or a partner who shares our mission, we would love to hear from you.






    FAQs

    What stage do you invest in?

    We provide growth capital to ventures that are ready to expand globally

    We focus on innovations from emerging markets with potential to scale into developed markets such as the US, EU, UK, and GCC.
    We invest in clinical and non-clinical solutions leveraging AI, big data, and novel technologies, along with health infrastructure and expansion models that drive sustainable growth in healthtech.
    We participate based on fit and round dynamics, and help syndicate with global venture partners.
    Through our network of hospitals and providers, we facilitate feedback sessions and pilot explorations, allowing solutions to be tested in real-world environments.

    Email reach@abgdventures.com or use the contact form on this site.